
Rabogrik L 75mg/20mg Capsule SR
Marketer
Greek Pharma
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rabogrik L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication, Acidex LR 75mg/20mg Extended-Release Capsules. This medication lessens excessive stomach acid production and prevents its backflow into the esophagus. Acidex LR 75mg/20mg Extended-Release Capsules are administered as directed by your physician, with or without food. Dosage and treatment duration are individualized based on your response and condition. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and influenza-like symptoms. These are generally transient and self-limiting. Report any concerning side effects to your doctor immediately. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until you assess your response. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Lifestyle adjustments, including a high-fiber diet, avoidance of trigger foods, increased fluid intake, and regular exercise, can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Rabogrik L 75mg/20mg Capsule SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Rabogrik L 75mg/20mg Capsule SR
Managing intestinal ulcers, irritable bowel syndrome, and gastroesophageal reflux disease (GERD).
Major Benefits of Rabogrik L 75mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rabogrik L 75mg/20mg sustained-release capsules on an empty stomach.
Common Side effects of Rabogrik L 75mg/20mg Capsule SR:
- Weakness
- Flatulence
- Vomiting
- Nausea
- Abdominal pain
- Diarrhea
- Headache
- Dizziness
- Breast enlargement in male
- Drowsiness
- Altered libido
- Absence of menstrual periods
- Unusual production of breast milk in women and men
- Cough
- Back pain
How to use Rabogrik L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rabogrik L 75mg/20mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
How Rabogrik L 75mg/20mg Capsule SR works:
Levosulpiride, a gastrointestinal motility stimulant, enhances acetylcholine release, boosting stomach and intestinal contractions and thus mitigating acid reflux. Rabeprazole, a proton pump inhibitor, decreases gastric acid production, thereby alleviating acid indigestion and ulcers.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Rabogrik L 75mg/20mg SR capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Rabogrik L 75mg/20mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Rabogrik L 75mg/20mg sustained-release capsules with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Rabogrik L 75mg/20mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rabogrik L 75mg/20mg sustained-release capsules to individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that this medication should be used with caution in such patients.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Rabogrik L 75mg/20mg sustained-release capsules. Dosage modification of Rabogrik L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Rabogrik L 75mg/20mg Capsule SR :
Should you forget to take a Rabogrik L 75mg/20mg Capsule SR, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Never take more than the prescribed amount at one time.
Facts to Know About Rabogrik L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
